- Home
- KLAC vs BMY Comparison
KLAC vs BMY Comparison
Compare KLAC & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLAC
- BMY
- Stock Information
- Founded
- KLAC 1975
- BMY 1887
- Country
- KLAC United States
- BMY United States
- Employees
- KLAC N/A
- BMY N/A
- Industry
- KLAC Electronic Components
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- KLAC Technology
- BMY Health Care
- Exchange
- KLAC Nasdaq
- BMY Nasdaq
- Market Cap
- KLAC 103.0B
- BMY 97.4B
- IPO Year
- KLAC N/A
- BMY N/A
- Fundamental
- Price
- KLAC $829.37
- BMY $49.10
- Analyst Decision
- KLAC Buy
- BMY Hold
- Analyst Count
- KLAC 21
- BMY 16
- Target Price
- KLAC $806.19
- BMY $58.93
- AVG Volume (30 Days)
- KLAC 1.2M
- BMY 14.1M
- Earning Date
- KLAC 07-23-2025
- BMY 07-25-2025
- Dividend Yield
- KLAC 0.81%
- BMY 5.05%
- EPS Growth
- KLAC 44.11
- BMY N/A
- EPS
- KLAC 27.49
- BMY 2.67
- Revenue
- KLAC $11,550,156,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- KLAC $25.31
- BMY N/A
- Revenue Next Year
- KLAC $2.78
- BMY N/A
- P/E Ratio
- KLAC $30.16
- BMY $18.40
- Revenue Growth
- KLAC 20.33
- BMY 4.62
- 52 Week Low
- KLAC $551.33
- BMY $39.35
- 52 Week High
- KLAC $896.32
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- KLAC 67.13
- BMY 53.31
- Support Level
- KLAC $740.44
- BMY $47.73
- Resistance Level
- KLAC $796.30
- BMY $48.93
- Average True Range (ATR)
- KLAC 19.65
- BMY 0.86
- MACD
- KLAC 0.94
- BMY 0.40
- Stochastic Oscillator
- KLAC 95.55
- BMY 97.54
About KLAC KLA Corporation
KLA is one of the largest semiconductor wafer fabrication equipment, or WFE, manufacturers in the world. It specializes in the market segment of semiconductor process control, wherein machines inspect semiconductor wafers during research and development and manufacturing for defects and verify precise measurements. In this section of the market, KLA holds a majority share. It also has a small exposure to the etch and deposition segments of the WFE market. It counts as top customers the largest chipmakers in the world, including TSMC and Samsung.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.